APIs per la ricerca e le impurità

N-(4-Amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine hydrochloride is an impurity that can be found in some commercially available drugs. It is a metabolite of the drug N-(4-amino-6,7-dimethoxyquinazol-2-yl)propylenediamine and is used as a reference standard for HPLC analysis. This compound has been shown to have antiplatelet activities.

Please enquire for more information about 5-Chloro-3-(piperazin-1-yl)benzol[D]isothiazole including the price, delivery time and more detailed product information at the technical inquiry form on this page

Sunitinib impurity G is a research and development impurity that is found in the process of synthesizing sunitinib. Sunitinib impurity G is an analytical standard that is soluble in methanol and is suitable for HPLC analysis. It has been shown to have high purity, excellent stability, and a low level of toxicity.

Please enquire for more information about 2-Amino-5-(2-bromoacetyl)benzonitrile hydrobromide including the price, delivery time and more detailed product information at the technical inquiry form on this page

9-Cis,13-cis-retinol 15-acetate is an impurity in drugs that are used to treat a variety of conditions including psoriasis, acne, and ichthyosis. It has been identified as an impurity in the drug product 9-cis, 13-cis retinoic acid (9CRA) through high performance liquid chromatography (HPLC). It has been found to be a metabolite of 9CRA and is not toxic.

Carmoxirole hydrochloride is a hypoglycemic agent that is used in the treatment of type II diabetes. It is an analog of pergolide mesylate, which is a dopamine receptor agonist and has been shown to cause carcinogenesis in laboratory animals. Carmoxirole hydrochloride is synthesized from the reaction of 3-hydroxy-2-quinuclidinyl benzilate with chloroacetaldehyde, followed by hydrolysis of the ester linkages with hydrochloric acid. It has a particle size of less than 10 μm and exhibits high lipophilicity as it passes through cell membranes and into the intracellular fluid. The drug acts on all types of receptors, including alpha 1-, alpha 2-, beta 1-, beta 2-, and dopaminergic receptors.

Please enquire for more information about Methyl 1-(4-bromophenyl)-1H-pyrazole-4-carboxylate including the price, delivery time and more detailed product information at the technical inquiry form on this page

Apremilast is a drug product that belongs to the class of drugs called phosphodiesterase 4 inhibitors. It acts by inhibiting the enzyme phosphodiesterase 4 (PDE4) and therefore blocks the degradation of specific signaling molecules, such as cyclic adenosine monophosphate (cAMP). Apremilast has been shown to have anti-inflammatory properties in preclinical studies and is being developed for the treatment of inflammatory diseases, including rheumatoid arthritis. Apremilast is not active against gram-positive bacteria or some other types of bacteria. Apremilast has been shown to have a low potential for drug interactions with other drugs metabolized by cytochrome P450 enzymes.

N-Acetylsulfathiazole is a sulfa drug that acts as an inhibitor of bacterial growth. It reacts with sulfonic acids in the receptor molecule and forms hydrogen chloride, which inhibits bacterial growth by denaturing proteins. N-Acetylsulfathiazole has been shown to be effective against bacteria such as E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, and Salmonella enterica. This antibiotic binds to the active site of the enzyme dihydropteroate synthase and inhibits pyrimidine synthesis by competing with para-aminobenzoic acid (PABA) for binding sites on the enzyme. The formation of PABA is necessary for the synthesis of folic acid (vitamin B9). N-Acetylsulfathiazole is also used to treat vitamin B6 deficiency caused by

Granisetron is a serotonin 5-hydroxytryptamine 3 (5-HT3) receptor antagonist. It is used in the prevention and treatment of nausea and vomiting caused by cytotoxic chemotherapy, radiation therapy, or surgery. Granisetron hydrochloride is a white to off-white powder with a molecular weight of 476.0. The chemical formula for granisetron hydrochloride is C22H24ClN2O2S. This drug has been shown to be efficient in the prevention and treatment of nausea and vomiting caused by cytotoxic chemotherapy, radiation therapy, or surgery. The potential impurities are as follows:
1) 1-Desmethyl 2-methyl granisetron
2) 2-Methyl granisetron
3) 2-Methyl 3-(4'-hydroxyphenyl)propionitrile
4) 2-(4'-Hydroxyphenyl)-3-(

Mometasone Furoate EP Impurity J is a natural, non-synthetic impurity found in the drug product Mometasone Furoate EP. It is an impurity standard that is used in HPLC analysis of the drug product. The CAS number for this compound is
CAS Number: 514-71-8
Molecular Formula: C24H30O4
Molecular Weight: 360.48
Synonyms: Mometasone Furoate EP Impurity J;5α-pregna-1,4-diene-3,20 dione, 16-[(6-chloro-3-pyridinyl)oxy]-11β,17α,21-(epoxy)-
Impurity Standard for Mometasone Furoate EP

Trans-trans-4,4'-Iminodimethylenedi(cyclohexanecarboxylic acid) is a hydrophobic particle that is soluble in water. It has an average particle diameter of 20 nm and a viscosity of 10 cps. Trans-trans-4,4'-Iminodimethylenedi(cyclohexanecarboxylic acid) is used in skin care products as a thickener and viscosity enhancer. It provides a silky feel to the skin and improves the skin's elasticity. This product also helps to protect the skin from UV radiation by forming a barrier on the surface of the skin. The natural polymer can be produced from glycerin or amide to produce different properties for different applications. Trans-trans-4,4'-Iminodimethylenedi(cyclohexanecarboxylic acid) is an amphoteric molecule that can react with both acidic

Please enquire for more information about N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page

4-Hydroxymethyl-5-methylimidazol (HMMI) is a corrosion inhibitor that is used in the production of nanomaterials. It has been shown to be an effective treatment for wastewater containing hydrochloric acid and organic solvents. The reaction between HMMI and the acids in wastewater forms a complex that prevents the corrosion of metal surfaces. HMMI can be synthesized by reacting aesculus with formaldehyde in an organic solvent, such as acetone or chloroform, at room temperature. HMMI has also been shown to have antiviral potency and is used in skin care products, such as lotions and shampoos, due to its ability to penetrate the skin barrier. Magnetic resonance spectroscopy (MRS) was used to study the effect of HMMI on skin cells, while electrochemical methods were used to investigate how it inhibits viral activity.

Please enquire for more information about Dehydro nicardipine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Bortezomib impurity 76 is an analytical reference material that is used in the development and production of pharmaceuticals. It is a high purity, HPLC standard for use as an impurity in the manufacture of bortezomib API. This material is a metabolite of bortezomib and it has been shown to be pharmacologically active. Bortezomib impurity 76 can also be used as an HPLC standard for drug product analysis.

Phenproxide is an analog of testosterone that has been used traditionally in Chinese medicine to treat tumors. It has been found to induce apoptosis in cancer cells by inhibiting kinases, which are enzymes that regulate cellular processes such as cell division and growth. Phenproxide has also been shown to inhibit the activity of somatostatin, a hormone that regulates the release of other hormones. This inhibition may contribute to its anti-cancer properties. In addition, Phenproxide has been shown to have an effect on hyaluronan metabolism, a substance involved in tissue repair and inflammation. It is excreted in urine and may be used as a potential biomarker for cancer diagnosis or monitoring.

FR900359 is a drug product that is custom synthesized and characterized. It has a purity of 99% and CAS No. 107530-18-7. This product is used in metabolism studies, natural drug development, pharmacopoeia, and research and development. The impurity standard for this product is HPLC standard.

(betaR,deltaR)-2,3-Bis(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemicalcium salt is an impurity that is used in the production of a drug product. This product is metabolized to (betaR,deltaR)-2,3-bis(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-1H-pyrrole 1 heptanoic acid which is used as an analytical standard for HPLC.

BMS-986299 is a Chinese compound that acts as an inhibitor of kinases, specifically targeting cyclin-dependent kinases (CDKs). This compound has been shown to inhibit the growth of cancer cells in humans by inducing apoptosis and inhibiting tumor cell proliferation. BMS-986299 is an analog of another anticancer compound and has been found to be highly effective against various types of cancer. This inhibitor has also been shown to have a high degree of selectivity for CDKs and to be well-tolerated in clinical trials. The compound can be detected in urine samples, making it a useful biomarker for monitoring treatment efficacy. Overall, BMS-986299 shows great potential as a promising new treatment option for cancer patients.

Arbidol is a drug molecule that interacts with protease enzymes. It has been shown to inhibit human erythrocyte chymotrypsin, trypsin, and elastase. Arbidol is also able to inhibit the growth of bacteria such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The molecular modelling of arbidol suggests that it binds to the active site of the enzyme by blocking hydrophobic pockets on the surface of the enzyme. The conformational change in the protease enzyme activates arbidol's binding site for an extended period of time. This prolonged interaction prevents substrate from binding to the catalytic site of the enzyme and inhibits its activity.

KSI-3716 is a potent inhibitor of kinases, which are enzymes that play a critical role in cancer cell growth and survival. This inhibitor has been shown to be effective against Chinese and human kinases, making it a promising candidate for the treatment of various types of cancer. KSI-3716 is an analog of oseltamivir, a drug used to treat influenza. It has been found to induce apoptosis in tumor cells by inhibiting the activity of protein kinases. KSI-3716 also shows anticancer activity in vivo, as demonstrated by its ability to inhibit tumor growth in mice models. This inhibitor may have potential therapeutic applications for the treatment of cancer and other diseases related to kinase dysregulation.